You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 20 Next »

Project Scope 
Develop a BIMO Frequently asked Questions Forum to be posted on the PHUSE Advance Hub, following the same format as the SEND FAQ forum. This forum will utilize questions brought forward by the pharma/CRO community via public review, presentations, PHUSE BIMO team members, etc...
Problem Statement 

FDA drafted the initial Bioresearch Monitoring Technical Conformance Guide in December 2017, with an updated version published in July 2020. Reference: Bioresearch Monitoring Technical Conformance Guide - https://www.fda.gov/media/85061/download The guide provides specifications for preparing and submitting the following components in electronic format that are used by FDA for planning of Bioresearch Monitoring (BIMO) inspections.

  • Clinical Study-Level Information
  • Subject-Level Data Line Listings by Clinical Site
  • Summary-Level Clinical Site Dataset (clinsite.xpt)

NDA, BLA, and supplemental submissions to FDA require BIMO as a critical part of the electronic application. Pharma companies and CROs have individually developed BIMO standards based on the recent guidance from FDA. A coordinated approach to responses to Frequently asked BIMO questions can benefit sponsors as well as FDA.

Problem Impact 
A coordinated approach to BIMO Frequently Asked Questions can benefit sponsors as well as FDA. It was apparent during the creation of the PHUSE Bioresearch Monitoring Data Reviewer's Guide (BDRG) that organisations implementing BIMO Submission packages have outstanding questions. The BDRG team captured a lot of those questions in our Communication Tracker (repository of questions and team responses). While most questions were directed at the BDRG effort, there were many general questions that came up during review, presentations, etc...
Project Leads Email 

Julie Maynard (Johnson & Johnson)

jmaynar1@its.jnj.com

Sopan Kaith (Cytel)

sopan.kaith@cytel.com

Katie Warren (PHUSE Project Assistant)

katie@phuse.global 

CURRENT STATUS Q2/3 2022

Project approved Q3 2022.

Project Members Organisation 
Chunying YinJohnson & Johnson
Dyuthi YellamrajuGenentech
Jack Field AstraZeneca
Jean MulindeFDA
Kanaeko RavenellCBER
Kantish Chowdhury IQVIA
Kirsty Wall GSK
Mathura RamanathanIQVIA
Meng Li AstraZeneca 

Phyllis O’Hara Smetana

UCB

Rashed Hasan 

FDA 

Sai Ma 

Bayer 

Santosh Lingala 

Gilead

Srinivasan Ramasubramanian 

Abbvie

Triet Tran 

FDA
  • No labels